Jupiter Biosciences in talks to buy Swiss co; stock up
Jupiter Biosciences is in advanced discussion to buy privately-held Swiss pharma company SynphaBase for about $10 million to boost drug research capabilities and front-end sale of products internationally.
By ET Bureau |
MUMBAI: Jupiter Biosciences is in advanced discussion to buy privately-held Swiss pharma company SynphaBase for about $10 million to boost drug research capabilities and front-end sale of products internationally.
The stock was at Rs 31.85, up 0.63 per cent on the BSE. It touched a high of Rs 33 and low of Rs 31.25 in trade so far. Around 13.56 lakh shares were traded in the counter.
The stock was at Rs 31.85, up 0.63 per cent on the BSE. It touched a high of Rs 33 and low of Rs 31.25 in trade so far. Around 13.56 lakh shares were traded in the counter.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
